These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25023344)

  • 21. [Molecular diagnosis and therapy in oncology].
    Baretton G; Grabbe S; Keilholz U; Sauter G
    Onkologie; 2011; 34 Suppl 2():5-9. PubMed ID: 21447986
    [No Abstract]   [Full Text] [Related]  

  • 22. [Targeted therapy of a cancer patient is multiprofessional collaboration].
    Ristimäki A; Kytölä S; Haglund C; Bono P
    Duodecim; 2013; 129(10):1071-9. PubMed ID: 23767137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
    Merlio JP
    Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
    [No Abstract]   [Full Text] [Related]  

  • 24. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
    Arnedos M; Vielh P; Soria JC; Andre F
    J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of molecular genetic analysis in selecting antitumor therapy].
    Imianitov EN; Moiseenko VM
    Vopr Onkol; 2008; 54(2):121-32. PubMed ID: 18522159
    [No Abstract]   [Full Text] [Related]  

  • 26. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 27. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs.
    Amir E; Seruga B; Martinez-Lopez J; Kwong R; Pandiella A; Tannock IF; Ocaña A
    J Clin Oncol; 2011 Jun; 29(18):2543-9. PubMed ID: 21606435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pathologist and targeted therapies in oncology].
    Bertheau P
    Ann Pathol; 2009 Nov; 29 Spec No 1():S69-70. PubMed ID: 19887258
    [No Abstract]   [Full Text] [Related]  

  • 29. Companion diagnostics.
    Becker R; Mansfield E
    Clin Adv Hematol Oncol; 2010 Jul; 8(7):478-9. PubMed ID: 20864915
    [No Abstract]   [Full Text] [Related]  

  • 30. How next-generation sequencing could change cancer care.
    O'Hanlon LH
    J Natl Cancer Inst; 2013 Jun; 105(12):836-8. PubMed ID: 23733908
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeted therapy: overcoming drug resistance with clinical cancer genome.
    Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biomarkers of response to molecular targeted therapy in renal cell carcinoma].
    Mizuno R; Oya M
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1088-91. PubMed ID: 21772092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized lung cancer treatment based on molecular determinants.
    Simon GR
    J S C Med Assoc; 2011 Oct; 107(5):183-4. PubMed ID: 22057801
    [No Abstract]   [Full Text] [Related]  

  • 34. Biomarker debate highlights retrospective challenge.
    Jones D
    Nat Rev Drug Discov; 2009 Mar; 8(3):179-80. PubMed ID: 19247294
    [No Abstract]   [Full Text] [Related]  

  • 35. DNA repair: a reinvigorated therapeutic target.
    Bates SE
    Clin Cancer Res; 2010 Sep; 16(18):4510. PubMed ID: 20823139
    [No Abstract]   [Full Text] [Related]  

  • 36. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
    Scolyer RA; Thompson JF
    J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
    [No Abstract]   [Full Text] [Related]  

  • 37. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B
    J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BDNF/TrkB signaling as an anti-tumor target.
    Roesler R; de Farias CB; Abujamra AL; Brunetto AL; Schwartsmann G
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1473-5. PubMed ID: 21999118
    [No Abstract]   [Full Text] [Related]  

  • 40. [Individualized anticancer therapies: which regulatory guidelines?].
    Bedairia N; Marty M
    Bull Cancer; 2008 Oct; 95(10):985-8. PubMed ID: 19004730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.